Can Handwriting Speed Predict Early Cognitive Decline?

Summary: The timing and structure of a person’s handwriting can provide an objective, non-invasive marker of cognitive decline. Researchers in Portugal measured subtle motor changes during writing using an inking pen on a digitizing tablet and found that demanding dictation tasks reveal disruptions in timing and stroke organization that distinguish older adults with cognitive impairment from those without.

By capturing fine-grained kinematic data, the team demonstrated that complex dictation places heavy demands on working memory and executive control, causing handwriting to become slower, more fragmented, and less coordinated in people showing cognitive decline.

Key Facts

  • A window into brain function: Handwriting integrates fine motor control with sensory processing, organization and planning, making it a cognitively demanding task sensitive to changes in neural systems supporting those functions.
  • Digitized assessment: The study tested 58 older adults (ages 62–92) living in care homes; 38 had a previous diagnosis of cognitive impairment. Participants wrote on a digitizing tablet using an active inking pen while researchers recorded kinematic features.
  • Simple motor tasks are insufficient: Basic pen-control activities—drawing horizontal lines or tapping dots—did not separate groups. These tasks rely mainly on automated motor pathways and mask subtle cognitive differences.
  • Dictation acts as a cognitive stress test: Writing from dictation exposed clear differences between groups. Dictation requires listening, language processing, holding words in working memory, transforming sound to written form, and precise motor execution simultaneously.
  • Key predictive features: For short dictated sentences, start time and number of strokes were the strongest predictors of impairment. For longer or more complex sentences, vertical letter size, start time, and total duration became the most informative indicators of cognitive strain.
  • Scalable clinical promise: Because the method uses widely available tablets and simple writing tasks, it could become a low-cost, non-invasive screening tool to monitor cognitive trajectories in clinical and care settings.

Source: Frontiers

Handwriting blends fine motor skill with a set of cognitive abilities—selection, organization and interpretation of sensory information—so changes in writing can reflect declines in those systems. With age, handwriting often grows slower and more fragmented, which may signal emerging cognitive difficulties.

In a recent study published in Frontiers in Human Neuroscience, a Portuguese research team tested whether kinematic handwriting features—such as speed, stroke count and letter size—differ between older adults with cognitive impairment and those without, and whether those features might serve as practical diagnostic markers.

This shows an older person writing.
Digitized handwriting data in Frontiers in Human Neuroscience indicate that demanding dictation tasks reveal early cognitive decline through measurable changes in stroke timing and fragmentation. Credit: Neuroscience News

“Writing is more than movement; it reflects how the brain plans, organizes and executes complex actions,” said senior author Dr. Ana Rita Matias, assistant professor in the Department of Sport and Health at the University of Évora.

“We observed distinct timing and organizational patterns in the handwriting of older adults with cognitive impairment. Tasks that required greater cognitive effort highlighted these differences, showing that cognitive decline can be detected in the temporal structure and coherence of pen movements.”

Ready, set, write

The researchers aimed to determine whether the handwriting process—captured as kinematic data—could provide earlier or more sensitive indicators of cognitive decline than conventional outcome-focused assessments. The sample included 58 older adults in residential care, of whom 38 had a prior diagnosis of cognitive impairment. Participants completed simple pen-control tasks and several handwriting-speed exercises on a digitizing tablet with an inking pen.

Pen-control trials asked participants to draw 10 horizontal lines within 20 seconds and to produce at least 10 dots in the same time window. Handwriting tasks required copying and dictating two sentences of differing complexity, presented either on a card or read aloud.

Simple pen-control measures did not separate the cognitively impaired and unimpaired groups, confirming that basic, automated motor actions are not sensitive to early cognitive changes. Copying tasks showed a trend but were not reliably different between groups. Dictation, however, produced statistically significant differences, likely due to its higher demands on working memory and executive functions.

“Dictation forces multiple cognitive systems to work in parallel—listening, decoding language, holding content in working memory, transcribing it, and coordinating precise movements. When executive control or memory is compromised, hesitation and fragmentation become visible in the pen’s trajectory,” Matias explained.

For the shorter dictated sentence, start time and number of strokes were the most informative predictors of impairment. For the more complex sentence, vertical letter size, start time and total duration emerged as key indicators. The pattern suggests some handwriting features degrade earlier, while others remain preserved until later stages of decline.

Routine writing

Because this approach uses inexpensive digitizing tablets and brief, simple tasks, it holds promise as a practical screening and monitoring tool in clinics, care homes and primary-care settings. It is non-invasive and quick to administer, making it feasible to include in routine checkups to track changes over time.

The authors caution that the method is still being validated. Larger, more diverse samples and longitudinal studies are needed to confirm these findings and to understand how medications or other factors might influence handwriting kinematics. For now, the results show strong potential rather than clinical readiness.

“Our objective is a low-cost, easy-to-use assessment that can be integrated into everyday healthcare without specialized equipment,” Matias said. “With further validation, digital handwriting analysis could become a routine tool to monitor cognitive health.”

Key Questions Answered:

Q: If my handwriting has always been messy or slow, does that mean I am at risk for cognitive decline?

A: No. The approach compares an individual’s current handwriting efficiency and coherence against their own baseline trends rather than judging aesthetic neatness. The system identifies when writing becomes distinctly slower, choppier or more fragmented relative to a person’s usual pattern—signs that may reflect emerging cognitive difficulty.

Q: Why does dictation reveal cognitive problems when a simple drawing task does not?

A: Drawing lines or dots largely taps automated motor programs and requires minimal active cognitive processing. Dictation acts like a multitasking stress test: it demands listening, language decoding, working memory, symbol conversion and precise motor control at once. When executive resources are impaired, those competing demands cause hesitation and fragmentation that show up in pen kinematics.

Q: How soon could digital pen tracking become part of routine cognitive screening?

A: This is an emerging research area that needs broader validation across larger and more varied populations. Because it uses accessible tablets and non-invasive software, the long-term aim is to integrate brief handwriting scans into routine healthcare—but further evidence is required before it becomes a standard clinical tool.

Editorial Notes:

  • This article was edited by a Neuroscience News editor.
  • The original journal paper was reviewed in full by the editorial team.
  • Additional context was added by staff to clarify methods and implications.

About this aging and cognition research news

Author: Deborah Pirchner
Source: Frontiers
Contact: Deborah Pirchner – Frontiers
Image: Image credit: Neuroscience News

Original Research: Open access.
“Handwriting Speed and Pen Motor Control in Older Adults With and Without Cognitive Impairment” by João Galrinho, Orlando Fernandes, Ana Rita Silva, Marta A. Gonçalves-Montera, and Ana Rita Matias. Frontiers in Human Neuroscience
DOI: 10.3389/fnhum.2026.1820193


Abstract

Handwriting Speed and Pen Motor Control in Older Adults With and Without Cognitive Impairment

Background:

Handwriting is a hierarchical cognitive–motor activity that integrates motor execution, visuospatial processing, working memory and executive control. Digital handwriting recording enables simultaneous analysis of process (kinematics) and product (final performance), offering a grounded method to detect cognitive vulnerability in aging.

Methods:

Fifty-eight older adults (20 cognitively healthy; 38 cognitively impaired), classified using education-adjusted MMSE cutoffs, completed pen-control tasks (DOTS, LINES) and four handwriting-speed tasks (two copy, two dictation) on a digitizing tablet. Nine standardized kinematic variables were analyzed with logistic and multiple linear regression models and corrections for multiple comparisons.

Results:

Pen-control tasks did not discriminate between groups. Handwriting-speed tasks, particularly dictation, showed significant group differences. Temporal efficiency and stroke-organization variables (for example, Duration and Number of Strokes) contributed to classification under higher cognitive demands. In cognitively impaired participants, stronger coupling between kinematic features and final writing performance was observed, with Start Time, Vertical Size and Duration predicting dictation outcomes.

Conclusion:

Handwriting kinematics—especially temporal and stroke-related measures—are sensitive to cognitive impairment when assessed under high cognitive–motor load. Digitally mediated handwriting tasks, notably dictation paradigms, present an ecologically valid, low-cost option for screening and monitoring cognitive decline in older adults.

Clinical trial registration: ClinicalTrials.gov, NCT06483438.